Skip to content

Amarantus Bioscience Holdings, Inc.

CIK 0001424812

← back to feed
Revenue (TTM)
$0
−100.0% YoY Q1 May 2016
Net Income (TTM)
−$19.6M
+7.6% YoY Q1 May 2016
EPS Diluted (TTM)
−$0.08
−60.0% YoY Q1 May 2016
Gross Margin
—
Q1 May 2016
Operating Margin
—
Q1 May 2016
Net Margin
—
Q1 May 2016
Free Cash Flow (TTM)
−$458.81K
Q1 May 2016
Cash
$100K
Q1 May 2016
Total Debt
$161.91K
Q1 May 2016
Shares Outstanding
68.27M sh
Q1 May 2016

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings